332 JOURNAL OF CHEMICAL RESEARCH 2010
obtained from Aldrich, Merck or Acros and were used without further
purification.
(0.419 g, 77%); m.p. 201–203 °C (dec.); IR (KBr) (νmax, cm−1): 3193
(N–H), 1770, 1726 and 1668 (C=O), 1500 (C=C); 1H NMR (CDCl3):
δH 1.20 and 1.24 (6 H, 2 t, 3JHH = 7.0 Hz, 2 –CH2CH3), 2.01–2.11 (10
H, m, 5 CH2), 3.72 (NHCH), 4.06–4.14 (4 H, m, 2 ABX3 overlapping
systems, 2 OCH2CH3), 4.76 (1 H, s, NCH), 7.14–7.88 (10 H, m,
2 C6H5), 8.84 (1 H, br s, NH…O=C); 13C NMR (CDCl3): 192.9, 184.8,
172.5, 172.3, 169.0, 157.5, 134.6, 129.4, 129.3, 129.0, 128.7, 128.1,
127.7, 126.4, 126.2, 77.4, 72.5, 62.1, 61.7, 51.6, 50.6, 42.8, 34.2, 33.5,
25.3, 24.9, 14.6, 14.1. Anal. Calcd for C32H33NO7 (543.60): C, 70.70;
H, 6.12; N, 2.58. Found: C, 70.58; H, 6.08; N, 2.55%.
Diethyl 2-[(1,1,3,3-tetramethylbutyl)amino]-5,6-dioxo-4a,7-diphenyl-
4,4a,5,6-tetrahydrocyclopenta[b]pyran-3,4-dicarboxylate (4g):
Yellow powder (0.379 g, 66%); m.p. 209–211 °C (dec.); IR (KBr)
(νmax, cm−1): 3367 (N–H), 1759, 1723 and 1680 (C=O), 1492 (C=C);
1H NMR (CDCl3): δH 0.84 (9 H, s, C(CH3)3), 1.19 and 1.26 (6 H, 2 t,
3JHH = 7.0 Hz, 2 -CH2CH3), 1.39 and 1.40 (6 H, 2 s, C(CH3)2), 1.46 and
1.75 (2 H, AB system, 2JHH=14.9 Hz, CH2), 4.10–4.15 (4 H, m, 2ABX3
overlapping systems, 2 OCH2CH3), 4.85 (1 H, s, NCH), 7.26–7.72
(10 H, m, 2 C6H5), 8.90 (1 H, br s, NH…O=C); 13C NMR (CDCl3):
δC 192.5, 185.5, 172.4, 172.1, 168.8, 159.2, 134.0, 129.7, 129.3,
129.0, 128.7, 127.6, 127.1, 126.7, 77.3, 74.0, 62.3, 61.6, 57.2, 53.1,
52.1, 42.6, 31.9, 31.1, 30.9, 14.3, 14.0. Anal. Calcd for C34H39NO7
(573.67): C, 71.18; H, 6.85; N, 2.44. Found: C, 70.97; H, 6.78;
N, 2.41%.
Preparation of 4a; typical procedure
To a magnetically stirred solution of 3,5-diphenylcyclopentane-
1,2,4-trione (0.264 g, 1.0 mmol) and tert-butyl isocyanide (0.084 g,
1.0 mmol) in dry acetone (20 ml) was added dropwise a mixture
of dimethyl acetylenedicarboxylate (0.142 g, 1.0 mmol) in acetone
(2 ml) at room temperature over 10 min via a syringe. The reaction
mixture was stirred at room temperature for 24 h. The solvent was
removed under reduced pressure and the solid residue was washed
with diethyl ether and crystallised from CH2Cl2: n–hexane (1:5) to
give 4a as a yellow powder (0.368 g, 75%). The dried product thus
obtained showed a single spot on TLC and was pure enough for all
analytical purposes.
Dimethyl 2-(tert-bytylamino)-5,6-dioxo-4a,7-diphenyl-4,4a,5,6-tet
rahydrocyclopenta[b]pyran-3,4-dicarboxylate (4a): M.p. 166–168 °C
(dec.); IR (KBr) (νmax, cm−1): 3168 (N–H), 1774, 1723, 1668 and 1629
(C=O), 1493 (C=C); 1H NMR (CDCl3): δH 1.35 (9 H, s, C(CH3)3), 3.63
and 3.68 (6 H, 2 s, 2 OCH3), 4.76 (1 H, s, NCH), 7.29–7.80 (10 H, m,
2 C6H5), 8.90 (1 H, br s, NH…O=C); 13C NMR (CDCl3): δC 192.9,
185.6, 172.3, 172.1, 169.1, 159,3, 134.1, 129.7, 129.4, 129.0, 128.9,
128.6, 127.5, 127.2, 126.3, 77.3, 73.8, 53.2, 52.8, 51.6, 42.8, 30.4.
Anal. Calcd for C28H27NO7 (489.51): C, 68.70; H, 5.56; N, 2.86.
Found: C, 68.47; H, 5.60; N, 2.88%.
Diethyl 2-(benzylamino)-5,6-dioxo-4a,7-diphenyl-4,4a,5,6-tetrahy-
drocyclopenta[b]pyran-3,4-dicarboxylate (4h):Yellow powder (0.326
g, 59%); m.p. 202–204 °C (dec.); IR (KBr) (νmax, cm−1): 3230 (N–H),
1766, 1721 and 1670 (C=O), 1493 (C=C); 1H NMR (CDCl3): δH 1.21
The synthesis of 4b–h was performed under similar conditions as
for 4a.
Dimethyl 2-(cyclohexylamino)-5,6-dioxo-4a,7-diphenyl-4,4a,5,6-
tetrahydrocyclopenta[b]pyran-3,4-dicarboxylate (4b):Yellow powder
(0.428 g, 83%); m.p. 181–183 °C (dec.); IR (KBr) (νmax, cm−1): 3256
(N–H), 1769, 1719 and 1676 (C=O), 1495 (C=C); 1H NMR (CDCl3):
δH 1.99–2.01 (10 H, m, 5 CH2), 3.62 and 3.84 (6 H, 2 s, 2 OCH3), 3.74
(NHCH), 4.70 (1 H, s, NCH), 7.25–7.97 (10 H, m, 2 C6H5), 8.60 (1 H,
br s, NH…O=C); 13C NMR (CDCl3): 192.7, 185.4, 172.4, 172.3,
168.9, 157.8, 134.4, 129.5, 129.3, 128.9, 128.6, 128.3, 127.7, 126.4,
126.3, 77.2, 72.8, 52.8, 51.5, 51.1, 50.9, 42.8, 34.0, 33.4, 25.3, 24.7.
Anal. Calcd for C30H29NO7 (515.55): C, 69.89; H, 5.67; N, 2.72.
Found: C, 70.24; H, 5.64; N, 2.70%.
3
and 1.24 (6 H, 2 t, JHH = 7.0 Hz, 2 -CH2CH3), 4.09–4.15 (4 H, m,
2 ABX3 overlapping systems, 2 OCH2CH3), 4.33 and 4.38 (2 H, AB
2
system, JHH = 15.0 Hz, NHCH2Ph), 4.72 (1 H, s, NCH), 7.23–8.10
(10 H, m, 3 C6H5), 9.01 (1 H, br s, NH…O=C); 13C NMR (CDCl3):
δC 190.2, 186.0, 172.9, 172.5, 169.9, 159.9, 137.7, 134.3, 129.5,
129.2, 129.1, 128.9, 128.6, 128.5, 128.0, 127.4, 127.0, 126.6, 126.5,
77.4, 73.6, 62.3, 62.0, 48.5, 43.2, 14.3, 13.9.Anal. Calcd for C33H29NO7
(551.58): C, 71.86; H, 5.30; N, 2.54. Found: C, 71.57; H, 5.27;
N, 2.56%.
Dimethyl 2-[(1,1,3,3-tetramethylbutyl)amino]-5,6-dioxo-4a,7-
diphenyl-4,4a,5,6-tetrahydrocyclopenta[b]pyran-3,4-dicarboxylate
(4c): Yellow powder (0.426 g, 78%); m.p. 196–198 °C (dec.); IR
(KBr) (νmax, cm−1): 3437 (N–H), 1763, 1726 and 1673 (C=O), 1495
We would like to thank Iran Polymer and Petrochemical
Institute (IPPI) Research Council for the financial support.
1
(C=C); H NMR (CDCl3): δH 0.82 (9 H, s, C(CH3)3), 1.36 and 1.37
2
(6 H, 2 s, C(CH3)2), 1.48 and 1.78 (2 H, AB system, JHH = 15.0 Hz,
Received 3 May 2010; accepted 18 May 2010
Paper 1000101 doi: 10.3184/030823410X12753056300098
Published online: 2 July 2010
CH2), 3.63 and 3.69 (6 H, 2 s, 2 OCH3), 4.77 (1 H, s, NCH), 7.31–7.74
(10 H, m, 2 C6H5), 8.95 (1 H, br s, NH…O=C); 13C NMR (CDCl3):
δC 192.9, 185.6, 172.3, 172.2, 169.1, 159.0, 134.1, 129.5, 129.3,
128.9, 128.6, 127.9, 127.2, 126.4, 77.4, 73.5, 56.9, 53.0, 52.8, 51.6,
50.9, 42.4, 31.5, 31.1, 30.9. Anal. Calcd for C32H35NO7 (545.62):
C, 70.44; H, 6.47; N, 2.57. Found: C, 70.21; H, 6.51; N, 2.55%.
Dimethyl 2-(benzylamino)-5,6-dioxo-4a,7-diphenyl-4,4a,5,6-tetra-
hydrocyclopenta[b]pyran-3,4-dicarboxylate (4d): Yellow powder
(0.367 g, 70%); m.p. 160–162 °C (dec.); IR (KBr) (νmax, cm−1): 3155
(N–H), 1770, 1727 and 1666 (C=O), 1500 (C=C); 1H NMR (CDCl3):
δH 3.66 and 3.71 (6 H, 2 s, 2 OCH3), 4.36 and 4.40 (2 H, AB system,
2JHH = 14.8 Hz, NHCH2Ph), 4.80 (1 H, s, NCH), 7.20–8.07 (10 H, m,
3 C6H5), 8.96 (1 H, br s, NH…O=C); 13C NMR (CDCl3): δC 190.1,
185.3, 173.1, 172.5, 169.8, 159.7, 138.6, 134.5, 129.5, 129.2, 129.0,
128.9, 128.7, 128.5, 127.9, 127.8, 127.1, 126.8, 126.5, 77.5, 74.3,
53.1, 52.8, 48.5, 43.2. Anal. Calcd for C31H25NO7 (523.53): C, 71.12;
H, 4.81; N, 2.68. Found: C, 70.91; H, 4.78; N, 2.70%.
References
1
2
3
4
5
J.D. Sunderhaus and S.F. Martin, Chem. Eur. J., 2009, 15, 1300.
L. El Kaim and L. Grimaud, Tetrahedron, 2009, 65, 2153.
M. Syamala, Org. Prep. Proc. Int., 2009, 41, 1.
I. Akritopoulou-Zanze, Curr. Opin. Chem. Biol., 2008, 12, 324.
J.I. Dickstein and S.I. Miller, The chemistry of functional groups. the
chemistry of carbon-carbon triple bond, Part 2, S. Patai, ed.; Wiley:
Chichester, 1978; Chap. 19, p. 813.
6
A. Ramazani, A.R. Kazemizadeh, E. Ahmadi, N. Noshiranzadeh and
A. Souldozi, Curr. Org. Chem., 2008, 12, 59.
7
8
V. Nair, S. Devipriya and E. Suresh, Tetrahedron, 2008, 64, 3567.
V. Nair, R.S. Menon, A.R. Sreekanth, N. Abhilash and A.T. Biju, Acc.
Chem. Res., 2006, 39, 520.
9
V. Nair, A.U. Vinod, N. Abhilash, R.S. Menon, V. Santhi, R.L. Varma,
S. Viji, S. Mathew and R. Srinivas, Tetrahedron, 2003, 59, 10279.
Diethyl2-(tert-butylamino)-5,6-dioxo-4a,7-diphenyl-4,4a,5,6-tetra-
hydrocyclopenta[b]pyran-3,4-dicarboxylate (4e): Yellow powder
(0.373 g, 72%); m.p. 178–180 °C (dec.); IR (KBr) (νmax, cm−1): 3210
(N–H), 1769, 1721 and 1670 (C=O), 1498 (C=C); 1H NMR (CDCl3):
10 I. Yavari and M.T. Maghsoodlou, J. Chem. Res.(S), 1998, 386.
11 I. Yavari, M. Adib and M.H. Sayahi, J. Chem. Soc., Perkin Trans. 1, 2002,
2343.
12 M.B. Teimouri, R. Bazhrang, V. Eslamimanesh and A. Nouri, Tetrahedron,
2006, 62, 3016.
13 A. Shaabani, M.B. Teimouri, P. Mirzaei and H.R. Bijanzadeh, J. Chem.
Res.(S), 2003, 82.
14 M.B. Teimouri, Tetrahedron, 2006, 62, 10849.
15 M.B. Teimouri, F. Mansouri and R. Bazhrang, Tetrahedron, 2010, 66,
259.
16 I.Yavari, M.Anary-Abbasinejad,A.Alizadeh and Z. Hossaini, Tetrahedron,
2003, 59, 1289.
17 A. Alizadeh, S. Rostamnia, L.-G. Zhu, Tetrahedron, 2006, 62, 5641.
18 M.B. Teimouri and R. Bazhrang, Monatsh. Chem., 2009, 140, 513.
19 M.B. Teimouri and F. Mansouri, J. Comb. Chem., 2008, 10, 507.
3
δH 1.19 and 1.22 (6 H, 2 t, JHH = 7.0 Hz, 2 -CH2CH3), 1.33 (9 H,
s, C(CH3)3), 4.08–4.19 (4 H, m, 2 ABX3 overlapping systems,
2 OCH2CH3), 4.81 (1 H, s, NCH), 7.30–8.02 (10 H, m, 2 C6H5), 8.86
(1 H, br s, NH…O=C); 13C NMR (CDCl3): δC 192.1, 184.7, 172.2,
172.0, 169.6, 159,1, 134.2, 129.5, 129.2, 129.1, 128.7, 128.3, 127.8,
127.1, 125.9, 77.3, 74.1, 62.0, 60.7, 52.2, 42.7, 30.6, 14.1, 13.9. Anal.
Calcd for C30H31NO7 (517.56): C, 69.62; H, 6.04; N, 2.71. Found:
C, 69.91; H, 6.10; N, 2.68%.
Diethyl2-(cyclohexylamino)-5,6-dioxo-4a,7-diphenyl-4,4a,5,6-tetra-
hydrocyclopenta[b]pyran-3,4-dicarboxylate (4f): Yellow powder